Summary

The Middle East & Africa infectious disease diagnostics market was valued at US$ 1,193.19 million in 2022 and is expected to reach US$ 1,576.80 million by 2030; it is estimated to grow at a CAGR of 3.5% from 2022 to 2030.

Rising Incidence of Infectious Diseases Drive Middle East & Africa Infectious Disease Diagnostics Market

Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Program on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0-14 years. Also, ~1.5 million new HIV cases were reported globally in 2020. According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).

Middle East & Africa Infectious Disease Diagnostics Market Overview

The Rest of Middle East & Africa includes Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya. Increasing demand for infectious disease diagnostics and growing technological advancement in clinical diagnostic technologies are boosting the market growth in the Middle Eastern and Africa. Moreover, the presence of major market players in the countries in the Rest of Middle East and Africa is fueling the growth of the market. for instance, Todos Medical Ltd. is a leading company in Israel that deals with providing life-saving diagnostic solutions for the early detection of various diseases. In 2021, the company has announced its first commercial antibody test for COVID-19. Thus, the presence of players offering products and end users related, the development and innovation of diagnostic solutions in various countries of the region is further likely to be responsible for supporting the overall growth of the market.

Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Infectious Disease Diagnostics Market Segmentation

The Middle East & Africa infectious disease diagnostics market is segmented based on product, technology, application type, testing type, end user, and country.

Based on product, the Middle East & Africa infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment held the largest share in 2022.

By technology, the Middle East & Africa infectious disease diagnostics market is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic techniques, clinical biology, and others. The immunodiagnostics segment held the largest share in 2022. The molecular-based diagnostic techniques segment is further subsegmented into enzyme-linked immunosorbent assay (ELISA), western blotting analysis, and immunofluorescence assay. The molecular-based diagnostic techniques segment is further subsegmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), DNA microarrays, and others.

By application type, the Middle East & Africa infectious disease diagnostics market is bifurcated into laboratory testing and point-of-care testing. The laboratory testing segment held a larger share in 2022.

By testing type, the Middle East & Africa infectious disease diagnostics market is bifurcated into human testing and veterinary testing. The human testing segment held a larger share in 2022. The human testing segment is further subsegmented into HIV, hepatitis, HAIs, HPV, tuberculosis, influenza, and others.

By end user, the Middle East & Africa infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, research institutes, homecare settings, and others. The diagnostic laboratories segment held the largest share in 2022.

Based on country, the Middle East & Africa infectious disease diagnostics market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa infectious disease diagnostics market in 2022.

Abbott Laboratories, Bruker Corp, Cardinal Health Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, ACON Laboratories Inc, and DiaSorin SpA are some of the leading companies operating in the Middle East & Africa infectious disease diagnostics market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Middle East & Africa Infectious Disease Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Infectious Disease Diagnostics Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
5. Middle East & Africa Infectious Disease Diagnostics Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 Rising Incidence of Infectious Diseases
5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
5.4 Future Trends
5.4.1 Rising Number of Product Approvals and Launches
5.5 Impact Analysis:
6. Infectious Disease Diagnostics Market - Middle East & Africa Market Analysis
6.1 Middle East & Africa Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030
7. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product
7.1 Overview
7.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
7.3 Kits & Reagents
7.3.1 Overview
7.3.2 Kits & Reagents: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology
8.1 Overview
8.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
8.3 Biosensor-based
8.3.1 Overview
8.3.2 Biosensor-based: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Immunodiagnostics
8.4.1 Overview
8.4.2 Immunodiagnostics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
8.5 Molecular-Based Diagnostic Techniques
8.5.1 Overview
8.5.2 Molecular-Based Diagnostic Techniques: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
8.6 Clinical Biology
8.6.1 Overview
8.6.2 Clinical Biology: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type
9.1 Overview
9.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
9.3 Point-of-Care Testing
9.3.1 Overview
9.3.2 Point-of-Care Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratory Testing
9.4.1 Overview
9.4.2 Laboratory Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type
10.1 Overview
10.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
10.3 Human Testing
10.3.1 Overview
10.3.2 Human Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
10.4 Veterinary Testing
10.4.1 Overview
10.4.2 Veterinary Testing: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User
11.1 Overview
11.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
11.3 Diagnostic Laboratories
11.3.1 Overview
11.3.2 Diagnostic Laboratories: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals and Clinics
11.4.1 Overview
11.4.2 Hospitals and Clinics: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.5 Research Institutes
11.5.1 Overview
11.5.2 Research Institutes: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.6 Homecare Settings
11.6.1 Overview
11.6.2 Homecare Settings: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others: Middle East & Africa Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
12. Middle East & Africa Infectious Disease Diagnostics Market - Country Analysis
12.1 Middle East & Africa Infectious Disease Diagnostics Market - Country Analysis
12.1.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country
12.1.1.1 Saudi Arabia
12.1.1.1.1 Overview
12.1.1.1.2 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.1.3 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.1.4 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.1.4.1 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.1.4.2 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.1.5 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.1.6 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.1.6.1 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.1.7 Saudi Arabia: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12.1.1.2 South Africa
12.1.1.2.1 Overview
12.1.1.2.2 South Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.2.3 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.2.4 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.2.4.1 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.2.4.2 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.2.5 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.2.6 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.2.6.1 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.2.7 South Africa: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12.1.1.3 UAE
12.1.1.3.1 Overview
12.1.1.3.2 UAE: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.3.3 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.3.4 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.3.4.1 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.3.4.2 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.3.5 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.3.6 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.3.6.1 UAE: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.3.7 UAE: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12.1.1.4 Rest of Middle East & Africa
12.1.1.4.1 Overview
12.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
12.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
12.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
12.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
12.1.1.4.4.2 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
12.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
12.1.1.4.6 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
12.1.1.4.6.1 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
12.1.1.4.7 Rest of Middle East & Africa: Middle East & Africa Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bruker Corp
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Cardinal Health Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 F. Hoffmann-La Roche Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Trinity Biotech Plc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Danaher Corp
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Bio-Rad Laboratories Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 ACON Laboratories Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 DiaSorin SpA
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms